Layn-KO 基因敲除小鼠

1. Mälarstig, Anders, Grassmann, Felix, Dahl, Leo, Czene, Kamila, Hedman, Åsa K. 2023. Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. In Nature communications, 14, 7680. doi:10.1038/s41467-023-43485-8. https://pubmed.ncbi.nlm.nih.gov/37996402/

2. Pan, Jing-Hua, Zhou, Hong, Cooper, Laura, Pan, Yun-Long, Rong, Lijun. 2019. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. In Frontiers in immunology, 10, 6. doi:10.3389/fimmu.2019.00006. https://pubmed.ncbi.nlm.nih.gov/30761122/

3. Xiao, Shuxiu, Lu, Lili, Lin, Zhiyuan, Wu, Weizhong, Zhou, Yuhong. 2024. LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma. In Journal of hepatocellular carcinoma, 11, 1031-1048. doi:10.2147/JHC.S464806. https://pubmed.ncbi.nlm.nih.gov/38859944/

4. Chen, Qingjuan, Chen, Jiankang, Lu, Zuzhuang, He, Wenjing, Zhu, Chenjing. 2024. The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration. In Discover oncology, 15, 57. doi:10.1007/s12672-024-00913-5. https://pubmed.ncbi.nlm.nih.gov/38430385/